Pharmaxis lodges TGA application to market Bronchitol for CF in Australia
16th
Dec 09
Release Date: 16/12/2009 12:00am
Pharmaxis today announced that it had submitted an application with the Therapeutic Goods Administration (TGA) to market Bronchitol in Australia for the treatment of cystic fibrosis.
Categories: News and Media